Novonesis (novozymes) BNVZMF
13F holders, Q1 2025 (March 31)1holders
0new positions
0sold out
$58.06avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding Novonesis (novozymes) B (NVZMF) in their 13F filings, unchanged from Q4 2024. 0 opened new positions and 0 sold out. The largest holder was Boston Common Asset Management, LLC ($1.5M).
- Company
- Novonesis (novozymes) B
- Filed as
- NOVOZYMES A/S (Q1 2025)
- CUSIP
- K7317J133
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 8,365 shares bought, net +8,365 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Boston Common Asset Management, LLC | 0.04% | Add +48.9% | 25,466 | $1.5M |
"% of holder's portfolio" is NVZMF's weight in each manager's 13F, not the share of Novonesis (novozymes) B the manager owns.